Air Canada: Lowering Our Long-Term Air Travel Growth Assumptions for North America

We’ve reduced our fair value estimate of Air Canada stock.

Illustration of an airplane outlined in blue and half of an airplane outline in pink in front of a red background depicting their airline industry.

Key Morningstar Metrics for Air Canada

  • Fair Value Estimate
    : C$22.70
  • Morningstar Rating
    : ★★★★
  • Morningstar Economic Moat Rating
    : None
  • Morningstar Uncertainty Rating
    : High

We lowered our forecast for long-term air-travel growth, based on the observed relationships among global economic growth, demand for air travel, and North America’s share of global travel, which decreased our 2030 forecast of Canadian airline capacity by 2.5%.

Why it matters: Economic growth goes hand in hand with demand for air travel. We lowered our global assumption for the elasticity of that demand to GDP growth from 2.1 to 1.8 in the medium term, but we still think the relationship will settle down to about 1.4 in the long term.

  • Our forecast for 2030 worldwide available seat miles went from 8.93 billion to 8.89 billion, only dropping half a percentage point, compared with just over 7.00 billion flown in 2025, and our expectation for global GDP growth hasn’t changed from around 3.1% annually.
  • We held our assumption steady for the share of global air traffic that Canadian carriers will provide. This measure has held fairly steady at around 2.5% of global capacity, while it shrank for US carriers from over 40% in the 1990s to just under 20% in 2025. We now see the US ASM share below 15% by 2033.

The bottom line: Our new forecast has the general effect of shrinking US airlines’ addressable market beyond the 2027-28 timeframe and increasing future intensiveness of competition among North American airlines in the mature and crowded air travel market.

  • As a result, we’ve decreased our fair value estimate for no-moat Air Canada AC to C$22.70 per share from C$26.00, leaving the stock some 20% undervalued relative to our revised fair value estimate. With its High Uncertainty Rating, we wouldn’t consider the stock compelling above C$13.60.

Editor's Note: This analysis was originally published as a stock note by Morningstar Equity Research.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.